CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Quick Ratio

OXGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




OXGN Quick Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Current Liabilities Change 302.12 % 759.59 % 373.35 % 87.61 % 79.24 %
Y / Y Cash & cash equivalent Change 684.25 % -82.66 % -95.83 % -93.04 % -92.44 %
Quick Ratio MRQ 0.08 0.02 0.01 0.01 0.04
Overall Ranking # # # # #
Seq. Current Liabilities Change -3.16 % 25.08 % 152.13 % 31.67 % 107.02 %
Seq. Cash & cash equivalent Change 260.29 % 123.8 % 405.76 % -80.77 % -92.03 %



Quick Ratio second quarter 2020 Comment
Mateon Therapeutics Inc's Cash & cash equivalent grew by 260.29 % in II. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Mateon Therapeutics Inc's Quick Ratio to 0.08, Quick Ratio remained below Mateon Therapeutics Inc average.

Within Biotechnology & Drugs industry 186 other companies have achieved higher Quick Ratio than Mateon Therapeutics Inc in second quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are OXGN Segments?
See Quick Ratio OXGN on the trailing twelve month basis
Quick Ratio second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 187
Healthcare Sector # 742
Overall Market # 3693


Quick Ratio Statistics
High Average Low
44.39 10.84 0.01
(Mar 31 2015)   (Sep 30 2019)




Financial Statements
Mateon Therapeutics Inc's Current Liabilities $ 8 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Cash & cash equivalent $ 1 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Quick RatioJun 30 2020 MRQ Cash & cash equivalentJun 30 2020 MRQ Current Liabilities
Azurrx Biopharma Inc   0.13 $ 1.021  Millions$ 7.616  Millions
Cannis Inc   0.13 $ 1.171  Millions$ 9.244  Millions
Protalix Biotherapeutics inc   0.11 $ 4.843  Millions$ 42.415  Millions
Quest Patent Research Corp  0.10 $ 0.862  Millions$ 8.937  Millions
Conversion Labs Inc   0.09 $ 0.617  Millions$ 6.860  Millions
Guided Therapeutics Inc  0.09 $ 0.763  Millions$ 8.630  Millions
Mateon Therapeutics Inc  0.08 $ 0.661  Millions$ 8.217  Millions
Precipio Inc   0.08 $ 0.353  Millions$ 4.424  Millions
Gtx Corp  0.07 $ 0.255  Millions$ 3.457  Millions
American Bio Medica Corp  0.07 $ 0.225  Millions$ 3.135  Millions
Sunwin Stevia International Inc   0.05 $ 0.876  Millions$ 16.434  Millions
Cell Medx Corp   0.05 $ 0.045  Millions$ 0.943  Millions
Integrated Biopharma Inc  0.03 $ 0.402  Millions$ 13.099  Millions
Cannabis Global Inc   0.03 $ 0.085  Millions$ 2.822  Millions
American Cryostem Corp  0.03 $ 0.042  Millions$ 1.407  Millions
Gt Biopharma Inc   0.03 $ 0.851  Millions$ 28.562  Millions
Biovie Inc   0.03 $ 0.037  Millions$ 1.259  Millions
Mymetics Corp  0.02 $ 1.271  Millions$ 68.769  Millions
Hst Global Inc   0.02 $ 0.001  Millions$ 0.084  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ATXI's Profile

Stock Price

ATXI's Financials

Business Description

Fundamentals

Charts & Quotes

ATXI's News

Suppliers

ATXI's Competitors

Customers & Markets

Economic Indicators

ATXI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071